VerCell

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameVerCell
Drug Alias Nameallogeneic cell-based therapy (Enlivex therapeutics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionApoptosis modulatorsStem cells modulators
TargetsUpdating
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnlivex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnlivex Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A